Atrial natriuretic peptide gene G664A polymorphism and the risk of ischemic cerebrovascular disease
Authors:
- 13 November 2001
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 57 (9) , 1726-1728
Abstract
The atrial natriuretic peptide (ANP) gene may underlie stroke susceptibility and sensitivity to cerebral ischemia in an animal model of stroke. The authors investigate its role in humans by genotyping a polymorphism (G664A) in 436 patients with ischemic cerebrovascular disease and 295 community control subjects. The frequency of this variant was similar in both groups and across the different stroke subtypes. The ANP gene G664A polymorphism is therefore unlikely to be an important risk factor for ischemic stroke in this population.Keywords
This publication has 11 references indexed in Scilit:
- Genetic analysis of the atrial natriuretic peptide gene in essential hypertensionClinical Science, 2000
- Genetic analysis of the atrial natriuretic peptide gene in essential hypertensionClinical Science, 2000
- Altered Structure, Regulation, and Function of the Gene Encoding the Atrial Natriuretic Peptide in the Stroke-Prone Spontaneously Hypertensive RatCirculation Research, 1999
- The Gene Encoding Atrial Natriuretic Peptide and the Risk of Human StrokeCirculation, 1999
- Atrial Natriuretic Peptide Gene Delivery Reduces Stroke-Induced Mortality Rate in Dahl Salt-Sensitive RatsHypertension, 1999
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locusNature Genetics, 1997
- Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human diseaseNature Genetics, 1996
- Brain Barrier Tissues: End Organs for AtriopeptinsScience, 1987
- Nucleotide Sequences of the Human and Mouse Atrial Natriuretic Factor GenesScience, 1984